12.02
price up icon0.00%   0.00
after-market After Hours: 12.02
loading
Replimune Group Inc stock is traded at $12.02, with a volume of 330.63K. It is up +0.00% in the last 24 hours and up +3.98% over the past month. Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
See More
Previous Close:
$12.02
Open:
$12.08
24h Volume:
330.63K
Relative Volume:
0.53
Market Cap:
$821.22M
Revenue:
-
Net Income/Loss:
$-209.96M
P/E Ratio:
-4.0471
EPS:
-2.97
Net Cash Flow:
$-176.27M
1W Performance:
-2.12%
1M Performance:
+3.98%
6M Performance:
+72.95%
1Y Performance:
-15.35%
1-Day Range:
Value
$11.72
$12.33
1-Week Range:
Value
$11.22
$12.37
52-Week Range:
Value
$4.92
$14.72

Replimune Group Inc Stock (REPL) Company Profile

Name
Name
Replimune Group Inc
Name
Phone
(781) 222-9600
Name
Address
500 UNICORN PARK, WOBURN, MA
Name
Employee
331
Name
Twitter
@Replimune
Name
Next Earnings Date
2024-11-05
Name
Latest SEC Filings
Name
REPL's Discussions on Twitter

Replimune Group Inc Stock (REPL) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-17-23 Resumed Piper Sandler Overweight
Nov-19-21 Initiated Piper Sandler Overweight
Oct-15-21 Resumed BTIG Research Buy
Nov-17-20 Initiated BTIG Research Buy
Nov-02-20 Initiated Jefferies Buy
Oct-15-20 Upgrade H.C. Wainwright Neutral → Buy
Jul-01-20 Downgrade H.C. Wainwright Buy → Neutral
May-05-20 Initiated Barclays Overweight
Sep-04-19 Initiated ROTH Capital Buy
Jul-23-19 Initiated Chardan Capital Markets Buy
Jul-12-19 Upgrade JP Morgan Neutral → Overweight
Jul-08-19 Initiated H.C. Wainwright Buy
Apr-25-19 Initiated Wedbush Outperform
Jan-23-19 Downgrade JP Morgan Overweight → Neutral
Aug-14-18 Initiated JP Morgan Overweight
Aug-14-18 Initiated Leerink Partners Outperform
View All

Replimune Group Inc Stock (REPL) Latest News

pulisher
04:17 AM

Vanguard Group's Strategic Acquisition in Replimune Group Inc - GuruFocus.com

04:17 AM
pulisher
Oct 30, 2024

Replimune to Present at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - The Manila Times

Oct 30, 2024
pulisher
Oct 23, 2024

Non-melanoma Skin Cancer is Predicted to Exhibit Remarkable Growth During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.

Oct 23, 2024
pulisher
Oct 22, 2024

SG Americas Securities LLC Invests $251,000 in Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Oct 22, 2024
pulisher
Oct 18, 2024

Replimune Group, Inc. (NASDAQ:REPL) Given Average Recommendation of "Buy" by Analysts - MarketBeat

Oct 18, 2024
pulisher
Oct 16, 2024

It would be worthwhile to take a closer look at Replimune Group Inc (REPL) - US Post News

Oct 16, 2024
pulisher
Oct 15, 2024

Daily Progress: Replimune Group Inc (REPL) Drop -7.06, Closing at 10.67 - The Dwinnex

Oct 15, 2024
pulisher
Oct 15, 2024

Replimune Group Inc [REPL] Insider Selling: Time to sell? - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Replimune Group Inc Inc. (REPL) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle

Oct 15, 2024
pulisher
Oct 14, 2024

Replimune Group (NASDAQ:REPL) Stock Price Down 5.2%Here's What Happened - MarketBeat

Oct 14, 2024
pulisher
Oct 13, 2024

Learn to Evaluate (REPL) using the Charts - Stock Traders Daily

Oct 13, 2024
pulisher
Oct 13, 2024

Cubist Systematic Strategies LLC Buys 53,313 Shares of Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat

Oct 13, 2024
pulisher
Oct 10, 2024

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Oct 10, 2024
pulisher
Oct 09, 2024

Gaining Ground: Replimune Group Inc (REPL) Closes Higher at 11.74, Up 3.62 - The Dwinnex

Oct 09, 2024
pulisher
Oct 09, 2024

Investing in Replimune Group Inc (REPL) Is Getting More Attractive - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Replimune Group, Inc. (NASDAQ:REPL) Shares Sold by Dimensional Fund Advisors LP - MarketBeat

Oct 09, 2024
pulisher
Oct 07, 2024

Morgan Stanley's Strategic Reduction in Replimune Group Inc Holdings - GuruFocus.com

Oct 07, 2024
pulisher
Oct 04, 2024

Cubist Systematic Strategies LLC Increases Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Oct 04, 2024
pulisher
Oct 04, 2024

Replimune Group, Inc. (NASDAQ:REPL) Shares Purchased by Millennium Management LLC - MarketBeat

Oct 04, 2024
pulisher
Oct 03, 2024

Chief Financial Officer Hill Emily Luisa sale 8,938 shares of Replimune Group Inc [REPL] - Knox Daily

Oct 03, 2024
pulisher
Oct 02, 2024

Insiders At Replimune Group Sold US$863k In Stock, Alluding To Potential Weakness - Simply Wall St

Oct 02, 2024
pulisher
Oct 02, 2024

Replimune Group (NASDAQ:REPL) Sees Strong Trading Volume - MarketBeat

Oct 02, 2024
pulisher
Oct 02, 2024

REPL’s Stock Market Adventure: 41.16% YTD Growth Amidst Volatility - The InvestChronicle

Oct 02, 2024
pulisher
Oct 01, 2024

Replimune Group (NASDAQ:REPL) Trading Up 6.1% - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Is it possible to buy Replimune Group Inc(REPL) shares at a good price now? - US Post News

Oct 01, 2024
pulisher
Oct 01, 2024

Replimune to Present at Two Upcoming Investor Conferences - The Manila Times

Oct 01, 2024
pulisher
Oct 01, 2024

Replimune Group, Inc. (NASDAQ:REPL) Shares Sold by XTX Topco Ltd - Defense World

Oct 01, 2024
pulisher
Sep 30, 2024

Keeping an Eye on Replimune Group Inc (REPL) After Insider Trading Activity - Knox Daily

Sep 30, 2024
pulisher
Sep 30, 2024

Analytical Overview: Replimune Group Inc (REPL)’s Ratios Tell a Financial Story - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

Replimune Group Inc (REPL) expanding its growth trajectory ahead - SETE News

Sep 30, 2024
pulisher
Sep 30, 2024

Replimune Group's SWOT analysis: biotech stock poised for growth amid challenges - Investing.com

Sep 30, 2024
pulisher
Sep 29, 2024

Point72 DIFC Ltd Makes New $57,000 Investment in Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Sep 29, 2024
pulisher
Sep 29, 2024

Deerfield Management Company L.P. Series C Has $264,000 Stake in Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat

Sep 29, 2024
pulisher
Sep 29, 2024

Deerfield Management Company L.P. Series C Has $264,000 Stock Holdings in Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat

Sep 29, 2024
pulisher
Sep 26, 2024

An analyst sees good growth prospects for Replimune Group Inc (REPL) - SETE News

Sep 26, 2024
pulisher
Sep 26, 2024

Point72 Asia Singapore Pte. Ltd. Makes New $443,000 Investment in Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat

Sep 26, 2024
pulisher
Sep 25, 2024

Replimune Group (NASDAQ:REPL) Stock Price Up 3.8% on Analyst Upgrade - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Financial Metrics Unveiled: Replimune Group Inc (REPL)’s Key Ratios in the Spotlight - The Dwinnex

Sep 25, 2024
pulisher
Sep 24, 2024

JPMorgan Chase & Co. Increases Replimune Group (NASDAQ:REPL) Price Target to $17.00 - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Replimune Group (NASDAQ:REPL) Given New $17.00 Price Target at JPMorgan Chase & Co. - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

A stock that deserves closer examination: Replimune Group Inc (REPL) - US Post News

Sep 24, 2024
pulisher
Sep 24, 2024

Rhumbline Advisers Buys 5,732 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Replimune Group, Inc. (NASDAQ:REPL) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Sep 24, 2024
pulisher
Sep 23, 2024

Replimune Group, Inc. (NASDAQ:REPL) Receives Average Rating of “Buy” from Analysts - Defense World

Sep 23, 2024
pulisher
Sep 20, 2024

Replimune Group (NASDAQ:REPL) Shares Gap Up to $11.03 - Defense World

Sep 20, 2024
pulisher
Sep 19, 2024

Replimune Group, Inc. (NASDAQ:REPL) Shares Bought by Bank of New York Mellon Corp - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Arizona State Retirement System Takes Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

Replimune Group (NASDAQ:REPL) Shares Down 6.4% - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Its Stock Has Paid Off Big Time For Replimune Group Inc - SETE News

Sep 18, 2024
pulisher
Sep 18, 2024

Replimune Group (NASDAQ:REPL) Rating Reiterated by HC Wainwright - Defense World

Sep 18, 2024
pulisher
Sep 17, 2024

Are Replimune Group Inc’shares a good deal? - US Post News

Sep 17, 2024

Replimune Group Inc Stock (REPL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Replimune Group Inc Stock (REPL) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Xynos Konstantinos
Chief Medical Officer
Jun 07 '24
Sale
7.50
15,881
119,108
117,131
Sarchi Christopher
Chief Commercial Officer
May 16 '24
Sale
6.47
2,218
14,350
92,252
Schwendenman Andrew
Chief Accounting Officer
May 16 '24
Sale
6.47
2,298
14,868
38,238
Love Colin
Chief Operating Officer
May 16 '24
Sale
6.47
17,615
113,969
777,345
Astley-Sparke Philip
Executive Chairman
May 16 '24
Sale
6.47
37,928
245,394
1,487,350
Coffin Robert
Director
May 16 '24
Sale
6.47
11,464
74,172
1,821,872
Patel Sushil
Chief Executive Officer
May 16 '24
Sale
6.47
20,194
130,655
212,014
Xynos Konstantinos
Chief Medical Officer
May 16 '24
Sale
6.47
6,367
41,194
133,012
Xynos Konstantinos
Chief Medical Officer
Nov 16 '23
Sale
10.92
7,313
79,858
112,714
Sarchi Christopher
Chief Commercial Officer
Nov 16 '23
Sale
10.92
5,255
57,385
72,245
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Cap:     |  Volume (24h):